Viewing Opinion | StockChase
Teva Pharmaceutical (TEVA-N) opinion on 2017-09-12

Last Price Recorded: 13.8400 on 2017-11-17

ON STOCKCHASE SINCE Dec 2000

biotechnology/pharmaceutical
SELL

Cameron Hurst
Teva Pharmaceutical was $19.330 at time of opinion
Owned : Unknown

There is a long road for new management. A lot to do and very significant fundamental risks. There are a number of well-flagged horrendously long list of knocks against the company right now. It has recently had a nice upswing, so if you own it, lock it in and walk away.

BEARISH on CANADIAN MARKET

All opinions for TEVA-N (232)

45 BUY
4 BUY on WEAKNESS
43 COMMENT
38 DON'T BUY
13 HOLD
2 PARTIAL BUY
25 PAST TOP PICK
8 SELL
3 STRONG BUY
44 TOP PICK
1 VAGUE
4 WAIT
2 WATCH
View All

More experts covering TEVA-N

SAVE
Add TEVA-N to Watch List

All opinions for TEVA-N (232)

45 BUY
4 BUY on WEAKNESS
43 COMMENT
38 DON'T BUY
13 HOLD
2 PARTIAL BUY
25 PAST TOP PICK
8 SELL
3 STRONG BUY
44 TOP PICK
1 VAGUE
4 WAIT
2 WATCH
View All

More experts covering TEVA-N

SAVE
Add TEVA-N to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company